ANN ARBOR, Mich. — May 22, 2019 — Kraig Biocraft Laboratories Inc., a developer of spider silk-based fibers, announces today that it has submitted five new provisional patent applications, for technologies related to its recombinant spider silk technologies. These applications cover a broad range of technologies in the creation, screening, and production of new recombinant proteins. These new applications expand beyond the company’s publicly disclosed silkworm and silk technologies, to include advanced construction systems, methods, and non-native proteins.
In November of 2018, the company retained Workman Nydegger as its Intellectual Property counsel and expects to utilize their expertise in prosecuting these, and all future, patent applications.
“Our R&D team is constantly looking for opportunities to strengthen our competitive potions, products, and processes. The recently submitted provisional patent applications cover key technologies and processes, invented by Dr. Kane and our team, as well as new applications that build upon our technologies,” said Kraig’s COO Jon Rice. “These new technologies have the potential to significantly reduce future R&D costs and break open new markets for recombinant protein products, reaching far beyond silks and apparel.”
Posted May 22, 2019
Source: Kraig Biocraft Laboratories
